[{"address1": "1560 Trapelo Road", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "781 786 8230", "fax": "781 786 8866", "website": "https://www.dyne-tx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 192, "companyOfficers": [{"maxAge": 1, "name": "Mr. John G. Cox M.B.A.", "age": 61, "title": "CEO, President & Director", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 1028185, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Oxana  Beskrovnaya Ph.D.", "age": 63, "title": "Chief Innovation Officer", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 719521, "exercisedValue": 2172731, "unexercisedValue": 3736735}, {"maxAge": 1, "name": "Ms. Johanna  Friedl-Naderer", "age": 56, "title": "Chief Commercial Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 748769, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Douglas  Kerr M.B.A., M.D., Ph.D.", "age": 56, "title": "Chief Medical Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 745640, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Rajesh  Manchanda Ph.D.", "age": 57, "title": "Chief Technical Officer", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James P. Bilotta M.B.A.", "title": "Chief Digital & Information Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ranjan  Batra Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Wilson", "age": 52, "title": "Senior VP & Head of Legal", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lucia  Celona", "age": 58, "title": "Chief Human Resource Officer", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Debra  Feldman", "age": 53, "title": "Chief Regulatory Affairs Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 7, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 13.99, "open": 14.15, "dayLow": 14.03, "dayHigh": 15.01, "regularMarketPreviousClose": 13.99, "regularMarketOpen": 14.15, "regularMarketDayLow": 14.03, "regularMarketDayHigh": 15.01, "payoutRatio": 0.0, "beta": 1.163, "forwardPE": -4.6518984, "volume": 2562927, "regularMarketVolume": 2498610, "averageVolume": 2460728, "averageVolume10days": 1722860, "averageDailyVolume10Day": 1722860, "bid": 14.64, "ask": 14.76, "bidSize": 2, "askSize": 2, "marketCap": 1670904832, "fiftyTwoWeekLow": 6.36, "fiftyTwoWeekHigh": 47.45, "fiftyDayAverage": 10.7507, "twoHundredDayAverage": 21.734776, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1016736704, "profitMargins": 0.0, "floatShares": 94176170, "sharesOutstanding": 113667000, "sharesShort": 23198935, "sharesShortPriorMonth": 15267942, "sharesShortPreviousMonthDate": 1744675200, "dateShortInterest": 1747267200, "sharesPercentSharesOut": 0.2041, "heldPercentInsiders": 0.0069, "heldPercentInstitutions": 1.10418, "shortRatio": 7.74, "shortPercentOfFloat": 0.2347, "impliedSharesOutstanding": 113667000, "bookValue": 5.887, "priceToBook": 2.4970274, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -367129984, "trailingEps": -3.61, "forwardEps": -3.16, "enterpriseToEbitda": -2.572, "52WeekChange": -0.5333333, "SandP52WeekChange": 0.119305134, "quoteType": "EQUITY", "currentPrice": 14.7, "targetHighPrice": 66.0, "targetLowPrice": 14.0, "targetMeanPrice": 44.86667, "targetMedianPrice": 49.0, "recommendationMean": 1.53333, "recommendationKey": "buy", "numberOfAnalystOpinions": 15, "totalCash": 677491968, "totalCashPerShare": 5.96, "ebitda": -395312000, "totalDebt": 23330000, "quickRatio": 19.996, "currentRatio": 20.35, "debtToEquity": 3.487, "returnOnAssets": -0.39922002, "returnOnEquity": -0.64014, "freeCashflow": -176840128, "operatingCashflow": -319724992, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "DYN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 5.07505, "regularMarketPrice": 14.7, "postMarketTime": 1749241921, "regularMarketTime": 1749240001, "exchange": "NMS", "messageBoardId": "finmb_608699906", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Dyne Therapeutics, Inc.", "longName": "Dyne Therapeutics, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1600349400000, "postMarketChangePercent": -1.97279, "postMarketPrice": 14.41, "postMarketChange": -0.29, "regularMarketChange": 0.71, "regularMarketDayRange": "14.03 - 15.01", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2460728, "fiftyTwoWeekLowChange": 8.34, "fiftyTwoWeekLowChangePercent": 1.3113208, "fiftyTwoWeekRange": "6.36 - 47.45", "fiftyTwoWeekHighChange": -32.75, "fiftyTwoWeekHighChangePercent": -0.6902002, "fiftyTwoWeekChangePercent": -53.33333, "earningsTimestamp": 1746703800, "earningsTimestampStart": 1754909940, "earningsTimestampEnd": 1755259200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.61, "epsForward": -3.16, "epsCurrentYear": -3.87721, "priceEpsCurrentYear": -3.7913861, "fiftyDayAverageChange": 3.9492998, "fiftyDayAverageChangePercent": 0.3673528, "twoHundredDayAverageChange": -7.0347757, "twoHundredDayAverageChangePercent": -0.32366452, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-09-17", "marketState": "CLOSED", "corporateActions": [], "averageAnalystRating": "1.5 - Buy", "cryptoTradeable": false, "displayName": "Dyne Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-06-07"}]